Genmab A/S is listed on the NASDAQ OMX Copenhagen A/S under the ticker symbol GEN and is traded as part of the OMXC20. Genmab is committed to proactive interaction with our shareholders and to provide reliable and transparent information about our business, development programs and results in an open and timely manner. In this area you can find information about Genmab’s latest share price, our recent news flow and other relevant shareholder information related to our listing on Nasdaq.
Read Genmab's latest Company Announcements and Media Releases
Including Genmab's share price, analyst coverage, major shareholders and warrant program
Find out more about Genmab's new ADR Program
Access Genmab's financial reports, webcasts, presentations and more
Find detailed information about conferences & events Genmab participates in